What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His primary areas of study are Fibroblast growth factor, Cell biology, Internal medicine, Endocrinology and Fibroblast growth factor receptor.
He regularly ties together related areas like Signal transduction in his Fibroblast growth factor studies.
The various areas that David M. Ornitz examines in his Cell biology study include Genetics, SLIT3, Cellular differentiation, Mesoderm and FGF10.
David M. Ornitz combines subjects such as Dwarfism and Chondrocyte, Endochondral bone growth, Endochondral ossification with his study of Internal medicine.
His Endocrinology research is multidisciplinary, relying on both FGF8, Heart development, Indian hedgehog, SOX9 and Limb development.
David M. Ornitz interconnects Mutation, Missense mutation, Ligand, Alternative splicing and Fibroblast growth factor receptor 1 in the investigation of issues within Fibroblast growth factor receptor.
His most cited work include:
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. (2185 citations)
- Receptor specificity of the fibroblast growth factor family. (1738 citations)
- Fibroblast growth factors. (1725 citations)
What are the main themes of his work throughout his whole career to date?
David M. Ornitz spends much of his time researching Fibroblast growth factor, Cell biology, Internal medicine, Endocrinology and Fibroblast growth factor receptor.
The subject of his Fibroblast growth factor research is within the realm of Receptor.
His Cell biology research integrates issues from Chondrocyte and Cellular differentiation.
His Internal medicine research incorporates elements of Limb bud, Heart development and Cardiology.
His Endocrinology research focuses on FGF18 and how it relates to Chondrogenesis.
His studies in Fibroblast growth factor receptor integrate themes in fields like Molecular biology, Cancer research and Ligand.
He most often published in these fields:
- Fibroblast growth factor (57.73%)
- Cell biology (49.14%)
- Internal medicine (25.43%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (49.14%)
- Fibroblast growth factor (57.73%)
- Fibroblast growth factor receptor 1 (13.06%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cell biology, Fibroblast growth factor, Fibroblast growth factor receptor 1, Cancer research and FGF20.
The Cell biology study combines topics in areas such as Limb bud and Hair cell, Organ of Corti, Cochlea.
His Fibroblast growth factor study incorporates themes from PI3K/AKT/mTOR pathway and Signal transduction.
His research in Fibroblast growth factor receptor 1 intersects with topics in Fibroblast, Endocrinology and Insulin resistance.
In the subject of general Cancer research, his work in Angiogenesis is often linked to Bleomycin, thereby combining diverse domains of study.
His Fibroblast growth factor receptor research is multidisciplinary, incorporating elements of DUX4, Homeostasis and Osteoblast.
Between 2017 and 2021, his most popular works were:
- Dermal Condensate Niche Fate Specification Occurs Prior to Formation and Is Placode Progenitor Dependent (36 citations)
- Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation. (20 citations)
- Fibroblast growth factors in skeletal development. (14 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Fibroblast growth factor, Cell biology, Cancer research, Mesenchyme and Angiogenesis.
His Fibroblast growth factor study is mostly concerned with Fibroblast growth factor receptor, FGF9 and FGF10.
His work deals with themes such as Limb bud and FGF18, which intersect with Cell biology.
His Cancer research research is multidisciplinary, incorporating perspectives in Fibroblast growth factor receptor 1, Pulmonary fibrosis and Lung injury.
His Mesenchyme research incorporates themes from Cell signaling, Endochondral ossification, Intramembranous ossification and Osteoblast.
He focuses mostly in the field of Angiogenesis, narrowing it down to topics relating to Carcinogenesis and, in certain cases, Immune system, Lung cancer, Adenocarcinoma and Tyrosine kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
